Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review

There has been less volume of literature focusing on the Immune-related Hematological Adverse Drug Events (Hem-irAEs) of Immune Checkpoint Inhibitors (ICPis) in cancer patients. Furthermore, there has been no consensus about the management of hematological toxicity from immunotherapy in the recently...

Descripción completa

Detalles Bibliográficos
Autores principales: Omar, Nabil E., El-Fass, Kareem A., Abushouk, Abdelrahman I., Elbaghdady, Noha, Barakat, Abd Elmonem M., Noreldin, Ahmed E., Johar, Dina, Yassin, Mohamed, Hamad, Anas, Elazzazy, Shereen, Dermime, Said
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640759/
https://www.ncbi.nlm.nih.gov/pubmed/33193289
http://dx.doi.org/10.3389/fimmu.2020.01354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640759/
https://www.ncbi.nlm.nih.gov/pubmed/33193289
http://dx.doi.org/10.3389/fimmu.2020.01354

Ejemplares similares